186 related articles for article (PubMed ID: 21397598)
1. Adenovirus mediated homozygous endometrial epithelial Pten deletion results in aggressive endometrial carcinoma.
Joshi A; Ellenson LH
Exp Cell Res; 2011 Jul; 317(11):1580-9. PubMed ID: 21397598
[TBL] [Abstract][Full Text] [Related]
2. The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.
Liang X; Daikoku T; Terakawa J; Ogawa Y; Joshi AR; Ellenson LH; Sun X; Dey SK
PLoS Genet; 2018 Aug; 14(8):e1007630. PubMed ID: 30142194
[TBL] [Abstract][Full Text] [Related]
3. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias.
Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X
Dis Model Mech; 2013 May; 6(3):710-20. PubMed ID: 23471917
[TBL] [Abstract][Full Text] [Related]
4. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
[TBL] [Abstract][Full Text] [Related]
5. Activated mutant p110α causes endometrial carcinoma in the setting of biallelic Pten deletion.
Joshi A; Miller C; Baker SJ; Ellenson LH
Am J Pathol; 2015 Apr; 185(4):1104-13. PubMed ID: 25698082
[TBL] [Abstract][Full Text] [Related]
6. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.
Hayes MP; Wang H; Espinal-Witter R; Douglas W; Solomon GJ; Baker SJ; Ellenson LH
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5932-5. PubMed ID: 17062663
[TBL] [Abstract][Full Text] [Related]
8. Oviduct-specific glycoprotein is a molecular marker for invasion in endometrial tumorigenesis identified using a relevant mouse model.
Wang H; Joshi A; Iaconis L; Solomon GJ; Xiang Z; Verhage HG; Douglas W; Ronnett BM; Ellenson LH
Int J Cancer; 2009 Mar; 124(6):1349-57. PubMed ID: 19101990
[TBL] [Abstract][Full Text] [Related]
9. Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice.
Begum M; Tashiro H; Katabuchi H; Suzuki A; Kurman RJ; Okamura H
Lab Invest; 2006 Mar; 86(3):286-96. PubMed ID: 16402032
[TBL] [Abstract][Full Text] [Related]
10. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.
Daikoku T; Hirota Y; Tranguch S; Joshi AR; DeMayo FJ; Lydon JP; Ellenson LH; Dey SK
Cancer Res; 2008 Jul; 68(14):5619-27. PubMed ID: 18632614
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression.
van der Zee M; Jia Y; Wang Y; Heijmans-Antonissen C; Ewing PC; Franken P; DeMayo FJ; Lydon JP; Burger CW; Fodde R; Blok LJ
J Pathol; 2013 May; 230(1):48-58. PubMed ID: 23288720
[TBL] [Abstract][Full Text] [Related]
12. [Immunomorphologic features of epithelial-stromal relationships at hyperplasia and endometrial carcinoma].
Bantysh BB; Paukov vS; Kogan EA
Arkh Patol; 2012; 74(3):22-5. PubMed ID: 22937575
[TBL] [Abstract][Full Text] [Related]
13. Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.
Memarzadeh S; Zong Y; Janzen DM; Goldstein AS; Cheng D; Kurita T; Schafenacker AM; Huang J; Witte ON
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17298-303. PubMed ID: 20855612
[TBL] [Abstract][Full Text] [Related]
14. Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.
Kim TH; Lee DK; Cho SN; Orvis GD; Behringer RR; Lydon JP; Ku BJ; McCampbell AS; Broaddus RR; Jeong JW
Cancer Res; 2013 Aug; 73(16):5090-9. PubMed ID: 23811943
[TBL] [Abstract][Full Text] [Related]
15. PI3K/PTEN/AKT Genetic Mouse Models of Endometrial Carcinoma.
Joshi A; Ellenson LH
Adv Exp Med Biol; 2017; 943():261-273. PubMed ID: 27910071
[TBL] [Abstract][Full Text] [Related]
16. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
[TBL] [Abstract][Full Text] [Related]
18. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.
Feng ZZ; Chen JW; Yang ZR; Lu GZ; Cai ZG
Med Oncol; 2012 Mar; 29(1):304-10. PubMed ID: 21181309
[TBL] [Abstract][Full Text] [Related]
19. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
Zhou WX; Liang ZY; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]